- Home
- MP vs SLNO Comparison
MP vs SLNO Comparison
Compare MP & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MP
- SLNO
- Stock Information
- Founded
- MP 2017
- SLNO 1999
- Country
- MP United States
- SLNO United States
- Employees
- MP N/A
- SLNO N/A
- Industry
- MP Metal Mining
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MP Basic Materials
- SLNO Health Care
- Exchange
- MP Nasdaq
- SLNO Nasdaq
- Market Cap
- MP 2.7B
- SLNO 2.2B
- IPO Year
- MP N/A
- SLNO 2014
- Fundamental
- Price
- MP $24.31
- SLNO $46.13
- Analyst Decision
- MP Buy
- SLNO Strong Buy
- Analyst Count
- MP 11
- SLNO 5
- Target Price
- MP $21.86
- SLNO $71.20
- AVG Volume (30 Days)
- MP 3.4M
- SLNO 390.6K
- Earning Date
- MP 02-20-2025
- SLNO 03-05-2025
- Dividend Yield
- MP N/A
- SLNO N/A
- EPS Growth
- MP N/A
- SLNO N/A
- EPS
- MP N/A
- SLNO N/A
- Revenue
- MP $203,855,000.00
- SLNO N/A
- Revenue This Year
- MP N/A
- SLNO N/A
- Revenue Next Year
- MP $66.48
- SLNO N/A
- P/E Ratio
- MP N/A
- SLNO N/A
- Revenue Growth
- MP N/A
- SLNO N/A
- 52 Week Low
- MP $10.02
- SLNO $36.61
- 52 Week High
- MP $26.00
- SLNO $60.92
- Technical
- Relative Strength Index (RSI)
- MP 61.00
- SLNO 40.51
- Support Level
- MP $22.60
- SLNO $48.48
- Resistance Level
- MP $24.69
- SLNO $52.46
- Average True Range (ATR)
- MP 1.20
- SLNO 2.07
- MACD
- MP -0.16
- SLNO -0.47
- Stochastic Oscillator
- MP 59.67
- SLNO 0.94
About MP MP Materials Corp.
MP Materials Corp is the producer of rare earth materials in the Western Hemisphere. The company owns and operates the Mountain Pass Rare Earth Mine and Processing Facility, the only rare earth mining and processing site of scale in North America.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.